FPAS
Focus Partners Advisor Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-849
| Closed | -$538K | – | 1156 |
|
|
2025
Q1 | $538K | Buy |
+849
| New | +$538K | 0.01% | 568 |
|
|
2024
Q4 | – | Sell |
-371
| Closed | -$390K | – | 853 |
|
|
2024
Q3 | $390K | Buy |
371
+3
| +0.8% | +$3.15K | 0.01% | 502 |
|
|
2024
Q2 | $387K | Buy |
368
+158
| +75% | +$166K | 0.01% | 432 |
|
|
2024
Q1 | $202K | Buy |
+210
| New | +$202K | 0.01% | 583 |
|
|
2022
Q4 | – | Sell |
-451
| Closed | -$311K | – | 412 |
|
|
2022
Q3 | $311K | Buy |
+451
| New | +$311K | 0.02% | 299 |
|
|
2022
Q1 | – | Sell |
-342
| Closed | -$216K | – | 348 |
|
|
2021
Q4 | $216K | Buy |
+342
| New | +$216K | 0.05% | 130 |
|